Trial Profile
THE EFFECTS OF LEVOSIMENDAN ON ARTERIALL STIFFNESS IN PATIENTS WITH ADVANCED CHRONIC HEART FAILURE.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Jul 2011
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Chronic heart failure
- Focus Therapeutic Use
- 26 Jul 2011 New trial record